| 000 | 01589 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515234233.0 | ||
| 264 | 0 | _c20101006 | |
| 008 | 201010s 0 0 fre d | ||
| 022 | _a1769-6917 | ||
| 024 | 7 |
_a10.1684/bdc.2010.1165 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLim, C | |
| 245 | 0 | 0 |
_a[Prospective study of quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using oxaliplatin for peritoneal carcinomatosis]. _h[electronic resource] |
| 260 |
_bBulletin du cancer _cSep 2010 |
||
| 300 |
_a1053-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aCombined Modality Therapy _xadverse effects |
| 650 | 0 | 4 |
_aDiarrhea _xetiology |
| 650 | 0 | 4 |
_aFatigue _xetiology |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHealth Surveys |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperthermia, Induced _xadverse effects |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 |
_aPeritoneal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPostoperative Complications |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 700 | 1 | _aTordjmann, D | |
| 700 | 1 | _aGornet, J-M | |
| 700 | 1 | _aNemeth, J | |
| 700 | 1 | _aValleur, P | |
| 700 | 1 | _aPocard, M | |
| 773 | 0 |
_tBulletin du cancer _gvol. 97 _gno. 9 _gp. 1053-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1684/bdc.2010.1165 _zAvailable from publisher's website |
| 999 |
_c20031566 _d20031566 |
||